Dirk Roymans


Meet Dirk Roymans

Dirk has more than 20 years of experience in pharmaceutical discovery research and clinical drug development in mid-sized biotech and large pharma companies, and was a former Head of Respiratory Infectious Diseases Discovery at Janssen Pharmaceutica NV.

He has extensive knowledge of moving drugs from discovery into (early) clinical development across different disease indications, including (respiratory) antivirals, mycobacterial inhibitors, immunomodulators, anticancer drugs and drugs for animal health. Driven by his passion to bring new therapeutic solutions to patients and treat the world’s most devastating infectious diseases, he has discovered and progressed several molecules against respiratory syncytial virus (RSV), influenza A&B and Mycobacterium tuberculosis towards IND stage, of which rilematovir, a RSV fusion inhibitor, has recently reached Phase III clinical development.

Dirk is the founder and managing director of DNS Life Sciences Consulting, a company providing advice and professional services to large pharma companies, biotech SMEs and start-ups as well as academic partners in life sciences, by designing drug discovery strategies, guiding early-stage business model innovation, portfolio and project management, supporting product-market-fit optimization, as well as path-to-market design. He is an author on over 30 peer-reviewed publications of which some in leading journals like Science, Cell, Nature Chem Biol, Nature Commun and Proc Natl Acad Sci USA, and an inventor on over 15 different patent families.

Meet the Management Team & Founders

Head of Operations

Aleksandra Siekierska

Aleksandra has about 15 years of academic experience in the field of molecular and cell biology and neuroscience. She obta...

Johan Neyts

Johan Neyts is full professor of Virology at the KU Leuven, Belgium and Head of the Laboratory of Virology, Antiviral Drug...

Patrick Chaltin

Patrick Chaltin is the Managing Director of the Centre for Drug Design and Discovery (CD3) since its start-up in 2006.